Sign in
Taking people in United StatesNo phase

Tests diet and exercise to prevent knee osteoarthritis in women with obesity

Tests diet, exercise and weight-loss maintenance to prevent knee arthritis in women.

Key facts

Who runs it
Wake Forest University
Where
Boston, Chapel Hill, and Winston-Salem, United StatesSee the 3 sitesAlso in 1 other country, 1 site
Trial code
Registry title
The Osteoarthritis Prevention Study
Status
Recruiting
People taking part
1,230 people, planned
Started
21 Mar 2024
Expected to end
31 Jul 2029
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Diet and Exercise
Record updated
23 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 50 or older with obesity who have no knee osteoarthritis and no or only occasional knee pain. It tests diet, exercise and weight-loss maintenance to prevent knee osteoarthritis.

Age
50 years or older
Sex
Women only
Disease stage
No osteoarthritis in the knee on x-ray and MRI; no or infrequent knee pain (fewer than 15 days a month) in the same knee
Earlier treatment
No knee injection in the past 6 months; no knee fracture or ligament or meniscus injury in the past 12 months
Biomarker or test result
BMI of 30 kg/m2 or higher

Main reasons for not taking part

  • Severe or symptomatic coronary artery disease
  • Cannot walk without a device
  • Type 1 diabetes or active treatment for cancer
  • Knee osteoarthritis in both knees (by x-ray, MRI or frequent pain)
  • Cannot have an MRI (for example claustrophobia or body weight over 300 lbs (136 kg))

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • Female
  • BMI ≥ 30 kg/m2
  • An eligible knee will have no OA by xray and MRI
  • No or infrequent knee pain (< 15 days/month) in the same knee

Who cannot take part

  • during the past 12 months knee fracture, anterior cruciate ligament (ACL), medial collateral ligament (MCL), or meniscus injury with or without surgical repair
  • symptomatic or severe coronary artery disease
  • type 1 diabetes
  • active treatment for cancer
  • unable to walk without a device
  • blindness
  • knee injection during the past 6 months
  • bilateral knee OA by x-ray Kellgren-Lawrence (KL) ≥ 2
  • bilateral knee OA by MRI
  • bilateral symptomatic knee OA (frequent bilateral knee pain > 15 days per month)
  • BMI< 30.0 kg/m2
  • male sex
  • claustrophobia
  • contraindication to MRI including body weight > 300 lbs or knee coil does not fit
  • unwillingness or inability to change eating and physical activity habits due to environment
  • cannot speak and read English
  • planning to leave area > 2 months during the 48-month intervention period

Where in United States

Also in 1 other country, 1 site

  • Brigham and Women's HospitalBoston, United StatesContact: Paul OhTaking people
  • University of North Carolina at Chapel HillChapel Hill, United StatesContact: Jovita NewmanNo longer taking part
  • Wake Forest UniversityWinston-Salem, United StatesContact: Jovita NewmanTaking people

About the trial

What the trial wants to find out

The goal of this study is to establish the efficacy of an intervention of dietary weight loss, exercise, and weight-loss maintenance for knee Osteoarthritis (OA) prevention in adult females aged ≥ 50 years with obesity and no or infrequent knee pain. The primary aim is to compare the effects of a dietary weight loss, exercise, and weight-loss maintenance to an attention control group in preventing the development of structural Magnetic Resonance Imaging (MRI) knee OA. Secondary aims will determine the intervention effects on pain, mobility, health-related quality of life, knee joint compressive forces, inflammatory measures, weight loss, exercise self-efficacy, and cost-effectiveness of this intervention.

The 2 groups in the trial

  • Attention ControlNo study treatment, for comparison

    This comparison group provides attention, social interaction, and healthy lifestyle classes. There will be 4, 1-hour face-to-face group meetings per year featuring community health professionals, quarterly newsletters, and quarterly text messages.

  • Diet and ExerciseTreatment being tested

    The dietary component of the weight loss intervention is characterized by the frequency of contacts, methods to induce dietary restriction, and behavioral therapy strategies. The first 6 months of the diet program is an energy-restricted diet with the option of using partial meal replacements and nutritious snacks (Rapid Nutrition, PLC). The weight loss goal for the diet and exercise group is a minimum of 10% of baseline body weight by the end of year 1. The weight loss phase is followed by 3 years of a weight-loss maintenance program, with the goal of sustaining the achieved weight loss. The exercise component includes 60-minute sessions 2 days per week for 48 months.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Osteoarthritis Prevention Study
Plain-language title
Tests diet and exercise to prevent knee osteoarthritis in women with obesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
23 July 2026